Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 349.11M | 352.76M | 356.40M | 357.85M | 359.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 349.11M | 352.76M | 356.40M | 357.85M | 359.29M |
| Cost of Revenue | 132.43M | 134.65M | 136.86M | 138.32M | 139.77M |
| Gross Profit | 216.68M | 218.11M | 219.54M | 219.53M | 219.53M |
| SG&A Expenses | 165.09M | 165.09M | 165.08M | 162.26M | 159.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.98M | 6.96M | 5.95M | 4.99M | 4.03M |
| Total Operating Expenses | 321.44M | 323.14M | 324.84M | 323.05M | 321.27M |
| Operating Income | 27.68M | 29.62M | 31.57M | 34.80M | 38.03M |
| Income Before Tax | 32.54M | 31.83M | 31.12M | 34.13M | 37.13M |
| Income Tax Expenses | 3.78M | 3.79M | 3.80M | 4.02M | 4.23M |
| Earnings from Continuing Operations | 28.77 | 28.04 | 27.32 | 30.11 | 32.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.64M | -3.70M | -3.77M | -2.58M | -1.40M |
| Net Income | 25.13M | 24.34M | 23.55M | 27.53M | 31.50M |
| EBIT | 27.68M | 29.62M | 31.57M | 34.80M | 38.03M |
| EBITDA | 38.91M | 40.80M | 42.68M | 45.09M | 47.50M |
| EPS Basic | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 |
| EPS Diluted | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 |
| Average Basic Shares Outstanding | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B |
| Average Diluted Shares Outstanding | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 37.61% | 41.00% | 44.62% | 38.18% | 33.37% |